Published in J Nephrol on June 08, 2007
Personalized Medicine for Membranous Nephropathy (PMMN) | NCT03804359
Pathogenesis of membranous nephropathy: recent advances and future challenges. Nat Rev Nephrol (2012) 1.57
Melanocortin 1 receptor agonists reduce proteinuria. J Am Soc Nephrol (2010) 1.52
The renaissance of corticotropin therapy in proteinuric nephropathies. Nat Rev Nephrol (2011) 1.28
Membranous nephropathy in children: clinical presentation and therapeutic approach. Pediatr Nephrol (2009) 1.03
CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. Am J Pathol (2009) 0.92
Role of NADPH oxidase-mediated reactive oxygen species in podocyte injury. Biomed Res Int (2013) 0.92
Membranous nephropathy: not just a disease for adults. Pediatr Nephrol (2013) 0.84
Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: a report of two cases. Clin Exp Nephrol (2010) 0.83
Angioimmunoblastic T-cell lymphoma and membranous nephropathy: a still unreported association. Clin Exp Nephrol (2010) 0.83
Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library. PLoS One (2012) 0.82
An unusual case of membranous nephropathy associated with an ovarian tumor. Pediatr Nephrol (2011) 0.82
Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum. BMC Syst Biol (2012) 0.81
Percutaneous ultrasound-guided renal biopsy in children: a single centre experience. Hippokratia (2011) 0.81
EBV-positive diffuse large B-cell lymphoma in a patient with primary Sjögren's syndrome and membranous glomerulonephritis. BMC Nephrol (2012) 0.80
A novel Time-resolved Fluoroimmunoassay for the quantitative detection of Antibodies against the Phospholipase A2 Receptor. Sci Rep (2017) 0.79
Pulmonary thrombosis as the first manifestation of systemic lupus erythematosus in a 14-year-old boy. Pediatr Nephrol (2008) 0.79
Rapamycin ameliorates proteinuria and restores nephrin and podocin expression in experimental membranous nephropathy. Clin Dev Immunol (2013) 0.77
Novel targets for immunotherapy in glomerulonephritis. Biologics (2008) 0.77
Genetic susceptibility to idiopathic membranous nephropathy in high-prevalence Area, Taiwan. Biomedicine (Taipei) (2014) 0.77
Nephrotic syndrome: a watershed in the understanding of membranous nephropathy. Nat Rev Nephrol (2009) 0.76
Membranous nephropathy, leiomyoma and autoimmune myasthenia: more than a coincidence? Clin Kidney J (2012) 0.75
Onset of Graves' disease during long-term immunosuppressive therapy in a patient with membranous nephropathy. Endocrinol Diabetes Metab Case Rep (2015) 0.75
A Case of Membranous Glomerulonephritis with Superimposed Anti-Neutrophil Cytoplasmic Antibody-Associated Rapidly Progressive Crescentic Glomerulonephritis. Chonnam Med J (2015) 0.75
Pulmonary embolism revealing idiopathic membranous glomerulonephritis. Case Rep Med (2010) 0.75
Clinical Features and Outcomes in Patients With Membranous Nephropathy and Crescent Formation. Medicine (Baltimore) (2015) 0.75
Integrated profiling of microRNA expression in membranous nephropathy using high-throughput sequencing technology. Int J Mol Med (2013) 0.75
Risk alleles for IgA nephropathy-associated SNPs conferred completely opposite effects to idiopathic membranous nephropathy in Chinese Han. Immunol Res (2017) 0.75